Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel M Michaelson

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Journal of Neurochemistry|August 23, 2011
Anatomical localization of protease-activated receptor-1 and protease-mediated neuroglial crosstalk on peri-synaptic astrocytic endfeetEfrat Shavit, Daniel M Michaelson, Joab Chapman
Neurobiology of Aging|October 7, 2006
Neuron-specific susceptibility to apolipoprotein E4Haim Belinson, Iftach Dolev, Daniel M Michaelson
Molecular Neurodegeneration|May 21, 2013
ApoE4 induces Aβ42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 miceOri Liraz, Anat Boehm-Cagan, Daniel M Michaelson
BMC Medicine|March 21, 2019
ApoE4: an emerging therapeutic target for Alzheimer's diseaseMirna Safieh, Amos D Korczyn, Daniel M Michaelson
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Behavioral testing affects the phenotypic expression of APOE ε3 and APOE ε4 in targeted replacement mice and reduces the differences between themShiran Salomon-Zimri, Ori Liraz, Daniel M Michaelson
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 2, 2008
Activation of the amyloid cascade in apolipoprotein E4 transgenic mice induces lysosomal activation and neurodegeneration resulting in marked cognitive deficitsHaim Belinson, Dimitri Lev, Eliezer Masliah, et al.
Neuro-Degenerative Diseases|February 18, 2010
Possible role of tau in mediating pathological effects of apoE4 in vivo prior to and following activation of the amyloid cascadeDafna Inbar, Haim Belinson, Hanna Rosenman, et al.
Journal of Lipid Research|May 22, 2017
Omega-3 fatty acids, lipids, and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia preventionMarcus O W Grimm, Daniel M Michaelson, Tobias Hartmann
Neuro-Degenerative Diseases|March 7, 2008
Activation of the amyloid cascade by intracerebroventricular injection of the protease inhibitor phosphoramidonYotam Nisemblat, Haim Belinson, Iftach Dolev, et al.
Journal of Neurochemistry|August 2, 2007
Intraneuronal amyloid-beta plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulationOfir Levi, Iftach Dolev, Haim Belinson, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Journal of Neurochemistry|August 23, 2011
Anatomical localization of protease-activated receptor-1 and protease-mediated neuroglial crosstalk on peri-synaptic astrocytic endfeetEfrat Shavit, Daniel M Michaelson, Joab Chapman
Neurobiology of Aging|October 7, 2006
Neuron-specific susceptibility to apolipoprotein E4Haim Belinson, Iftach Dolev, Daniel M Michaelson
Molecular Neurodegeneration|May 21, 2013
ApoE4 induces Aβ42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 miceOri Liraz, Anat Boehm-Cagan, Daniel M Michaelson
BMC Medicine|March 21, 2019
ApoE4: an emerging therapeutic target for Alzheimer's diseaseMirna Safieh, Amos D Korczyn, Daniel M Michaelson
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Behavioral testing affects the phenotypic expression of APOE ε3 and APOE ε4 in targeted replacement mice and reduces the differences between themShiran Salomon-Zimri, Ori Liraz, Daniel M Michaelson
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 2, 2008
Activation of the amyloid cascade in apolipoprotein E4 transgenic mice induces lysosomal activation and neurodegeneration resulting in marked cognitive deficitsHaim Belinson, Dimitri Lev, Eliezer Masliah, et al.
Neuro-Degenerative Diseases|February 18, 2010
Possible role of tau in mediating pathological effects of apoE4 in vivo prior to and following activation of the amyloid cascadeDafna Inbar, Haim Belinson, Hanna Rosenman, et al.
Journal of Lipid Research|May 22, 2017
Omega-3 fatty acids, lipids, and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia preventionMarcus O W Grimm, Daniel M Michaelson, Tobias Hartmann
Neuro-Degenerative Diseases|March 7, 2008
Activation of the amyloid cascade by intracerebroventricular injection of the protease inhibitor phosphoramidonYotam Nisemblat, Haim Belinson, Iftach Dolev, et al.
Journal of Neurochemistry|August 2, 2007
Intraneuronal amyloid-beta plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulationOfir Levi, Iftach Dolev, Haim Belinson, et al.
Pageof 5